Revance Therapeutics Inc (NASDAQ:RVNC)

20.15
Data as of Sep 19
 -1.48 / -6.84%
Today’s Change
20.01
Today|||52-Week Range
39.86
--
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close21.63
Today’s open21.72
Day’s range20.01 - 21.94
Volume719,049
Average volume (3 months)190,349
Market cap$473.4M
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-364.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-13.95%
P/E ratio80.6
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XOMAXOMA Corp-0.04-0.87%
TTPHTetraphase Pharmaceu...+0.06+0.34%
ARRYArray Biopharma Inc-0.03-0.79%
VSARVersartis Inc-1.15-5.31%
Data as of 3:59pm ET, 09/19/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$617.0K
Annual profit (last year)$258.0K
Net profit margin41.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
CFO &
Executive VP-Corporate Development
Lauren P. Silvernail
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.